title: Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.
abstract: Triple-negative (TN) and basal-like (BL) breast cancer definitions have been used interchangeably to identify breast cancers that lack expression of the hormone receptors and overexpression and/or amplification of HER2. However, both classifications show substantial discordance rates when compared to each other. Here, we molecularly characterize TN tumors and BL tumors, comparing and contrasting the results in terms of common patterns and distinct patterns for each. In total, when testing 412 TN and 473 BL tumors, 21.4% and 31.5% were identified as non-BL and non-TN, respectively. TN tumors identified as luminal or HER2-enriched (HER2E) showed undistinguishable overall gene expression profiles when compared versus luminal or HER2E tumors that were not TN. Similar findings were observed within BL tumors regardless of their TN status, which suggests that molecular subtype is preserved regardless of individual marker results. Interestingly, most TN tumors identified as HER2E showed low HER2 expression and lacked HER2 amplification, despite the similar overall gene expression profiles to HER2E tumors that were clinically HER2-positive. Lastly, additional genomic classifications were examined within TN and BL cancers, most of which were highly concordant with tumor intrinsic subtype. These results suggest that future clinical trials focused on TN disease should consider stratifying patients based upon BL versus non-BL gene expression profiles, which appears to be the main biological difference seen in patients with TN breast cancer.
authors: Medical Oncology Department, Vall d’Hebron Institute of Oncology, Barcelona, Spain.
authors: Aleix
authors: A
authors: Prat
authors: Barbara
authors: B
authors: Adamo
authors: Maggie C U
authors: MC
authors: Cheang
authors: Carey K
authors: CK
authors: Anders
authors: Lisa A
authors: LA
authors: Carey
authors: Charles M
authors: CM
authors: Perou
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D064726:Triple Negative Breast Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases
references: Cancer Cell. 2012 May 15;21(5):626-641
references: 22624713
references: Cancer Cell. 2009 Aug 4;16(2):115-25
references: 19647222
references: Mod Pathol. 2010 Feb;23(2):205-12
references: 19898421
references: Breast Cancer Res. 2011;13(6):227
references: 22078026
references: PLoS One. 2009 Jul 03;4(7):e6146
references: 19582160
references: Nat Rev Clin Oncol. 2011 Dec 06;9(1):48-57
references: 22143140
references: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
references: 9843981
references: Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2772-7
references: 21940501
references: PLoS One. 2011 Feb 15;6(2):e17083
references: 21347235
references: Breast Cancer Res. 2010;12(1):R5
references: 20064235
references: J Clin Oncol. 2006 Sep 10;24(26):4236-44
references: 16896004
references: JAMA. 2011 May 11;305(18):1873-81
references: 21558518
references: Ann Oncol. 2010 Feb;21(2):283-290
references: 19628570
references: Nat Med. 2010 Feb;16(2):214-8
references: 20098429
references: Oncogene. 2005 Jul 7;24(29):4660-71
references: 15897907
references: J Natl Cancer Inst. 2011 Feb 2;103(3):264-72
references: 21191116
references: Breast Cancer Res. 2011 Sep 27;13(5):R94
references: 21952072
references: Oncogene. 2013 Mar 7;32(10):1296-304
references: 22525269
references: N Engl J Med. 2012 Jun 28;366(26):2455-65
references: 22658128
references: Nature. 2005 Jul 28;436(7050):518-24
references: 16049480
references: J Clin Oncol. 2011 Jan 1;29(1):e18-20
references: 21115855
references: EMBO Mol Med. 2011 Dec;3(12):726-41
references: 21910250
references: Breast Cancer Res Treat. 2012 Aug;135(1):301-6
references: 22752290
references: Nature. 2012 Oct 4;490(7418):61-70
references: 23000897
references: Nature. 2010 Apr 15;464(7291):999-1005
references: 20393555
references: Nature. 2000 Aug 17;406(6797):747-52
references: 10963602
references: J Natl Cancer Inst. 2008 Jun 4;100(11):805-14
references: 18505968
references: Breast Cancer Res. 2010;12(5):R68
references: 20813035
references: Breast Cancer Res. 2009;11(2):R15
references: 19272155
references: Genome Biol. 2003;4(5):P3
references: 12734009
references: Breast Cancer Res Treat. 2012 Apr;132(2):523-35
references: 21671017
references: BMC Med Genomics. 2011 Jan 09;4:3
references: 21214954
references: Breast Cancer Res Treat. 2010 May;121(1):53-64
references: 19593635
references: J Clin Oncol. 2005 Aug 1;23(22):5166-70
references: 16051958
references: Clin Exp Metastasis. 2012 Mar;29(3):273-92
references: 22271313
references: Lancet. 2005 Feb 19-25;365(9460):671-9
references: 15721472
references: Oncogene. 2012 Apr 26;31(17):2237-46
references: 21909135
references: J Clin Oncol. 2009 Mar 10;27(8):1160-7
references: 19204204
references: Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22231-6
references: 21127264
references: Clin Cancer Res. 2010 Nov 1;16(21):5222-32
references: 20837693
references: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
references: 11553815
references: J Clin Oncol. 2011 May 20;29(15):1949-55
references: 21483002
references: J Clin Oncol. 2010 Mar 1;28(7):1145-53
references: 20100965
references: Breast. 2012 Jun;21(3):354-60
references: 22464177
references: Nature. 2009 Jun 18;459(7249):1005-9
references: 19421193
references: Cancer Cell. 2006 Dec;10(6):515-27
references: 17157791
references: Clin Cancer Res. 2010 Nov 1;16(21):5351-61
references: 20829329
references: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references: 11309499
references: N Engl J Med. 2008 Mar 27;358(13):1409-11
references: 18367751
references: Mol Oncol. 2011 Feb;5(1):5-23
references: 21147047
references: Breast Cancer Res. 2012 Mar 15;14(2):R48
references: 22420471
references: Genome Biol. 2007;8(5):R76
references: 17493263
references: J Clin Oncol. 2010 Jun 1;28(16):2784-95
references: 20404251
references: Oncogene. 2006 Jun 29;25(28):3994-4008
references: 16491124
references: J Clin Invest. 2011 Jul;121(7):2750-67
references: 21633166